487 related articles for article (PubMed ID: 35897658)
1. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
2. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
3. Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.
Tringali C; Giussani P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887154
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
5. Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease.
Chakrabarti SS; Bir A; Poddar J; Sinha M; Ganguly A; Chakrabarti S
Curr Alzheimer Res; 2016; 13(11):1232-1248. PubMed ID: 27335046
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
7. The role of ceramide and SEW 2871 in the transcription of enzymes involved in amyloid b precursor protein metabolism in an experimental model of Alzheimer's disease.
Czubowicz K; Wójtowicz S; Wencel PL; Strosznajder RP
Folia Neuropathol; 2018; 56(3):196-205. PubMed ID: 30509041
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
9. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
12. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Katsel P; Li C; Haroutunian V
Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
[TBL] [Abstract][Full Text] [Related]
13. Role of sphingolipid metabolism in neurodegeneration.
Alaamery M; Albesher N; Aljawini N; Alsuwailm M; Massadeh S; Wheeler MA; Chao CC; Quintana FJ
J Neurochem; 2021 Jul; 158(1):25-35. PubMed ID: 32402091
[TBL] [Abstract][Full Text] [Related]
14. Ceramide Metabolism and Parkinson's Disease-Therapeutic Targets.
Custodia A; Aramburu-Núñez M; Correa-Paz C; Posado-Fernández A; Gómez-Larrauri A; Castillo J; Gómez-Muñoz A; Sobrino T; Ouro A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202192
[TBL] [Abstract][Full Text] [Related]
15. The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.
de Wit NM; Mol K; Rodríguez-Lorenzo S; de Vries HE; Kooij G
Front Immunol; 2020; 11():620348. PubMed ID: 33633739
[TBL] [Abstract][Full Text] [Related]
16. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
17. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
18. The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction.
Cirillo F; Piccoli M; Ghiroldi A; Monasky MM; Rota P; La Rocca P; Tarantino A; D'Imperio S; Signorelli P; Pappone C; Anastasia L
J Cell Physiol; 2021 Jul; 236(7):4857-4873. PubMed ID: 33432663
[TBL] [Abstract][Full Text] [Related]
19. Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
Petrache I; Berdyshev EV
Annu Rev Physiol; 2016; 78():463-80. PubMed ID: 26667073
[TBL] [Abstract][Full Text] [Related]
20. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
